Russian Venture Company (RVC), the Russian government’s fund of funds, has joined forces with the R-Pharm pharmaceutical company to launch a fund that will focus exclusively on investing in medical technology. RusBio Ventures will have the capacity to invest up to $39m in medical technology and in IT companies working in the biomedicine with at least 50% of investment being directed to Russian startups. The fund is initially looking to set up a portfolio of between eight and ten companies. Rusbase
Related News
- RVC teams up with Finematika to launch space technology…
- R-Pharm in Turkish biotech plant investment
- Sistema and TUS Holdings to launch $100m Sino-Russian high-tech…
- Skolkovo Innovation Centre to house Russian-Chinese business…
- FRII to invest $4m in Russian internet startups
- Promise of $3bn Saudi investment on table as Salman lands in…
- Medical advertising ban under review
- Second Runa technology investment fund launched